ReviewEngineering biology
Synthetic and Engineering Biology in Australia: Advances in Infrastructure, Coordination and Impact.
Review in Engineering biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthetic and Engineering Biology in Australia: Advances in Infrastructure, Coordination and Impact.Engineering biologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthetic and engineering biology in Australia is a vibrant and expanding area, with the potential to contribute to Australian priorities, industry growth and international initiatives. This paper provides a progress update on the field in Australia since 2021. The initial section provides historical context and an overview of the importance and potential impact. The second section focuses on the building and expansion of a strong community and mechanisms for coordination, noting need for industry coordination beyond the research sector. Governments have an important role in enabling development, with the Australian Government and State Governments implementing strategies and initiatives linked to national and regional priorities. The regulatory landscape for genetic technologies is also described, highlighting recent approvals and the overall enabling environment in Australia. The penultimate section provides details on major research initiatives, showing the growth in funding and how synthetic and engineering biology technologies are being developed and applied in an increasing range of application areas. Finally, there has been a notable expansion in the number of start-up companies and industry partnerships in Australia since 2021, with details provided about the companies and the drivers for this growth, as well as the challenges in accessing scale-up and commercialisation infrastructure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.